| Group A | Group B | P value |
---|---|---|---|
Gender (male: female) | 28: 13 | 27: 9 | 0.516* |
Age (years) | 49.2 ± 12.9 | 47.4 ± 11.6 | 0.535†|
  ≤ 50 (number) | 21 | 19 | 0.891* |
  > 50 (number) | 20 | 17 |  |
Contralateral eyes with BCVA <20/200 (number) | 16 | 5 | 0.013* |
Disease course (days) | 15.0 ± 8.7 | 11.94 ± 7.2 | 0.098†|
Follow-up duration (months) | 12.9 ± 4.5 | 13.6 ± 4.7 | 0.473†|
Preoperative logMAR BCVA (Snellen equivalent) | 1.22 ± 0.64 (20/332) | 1.12 ± 0.58 (20/264) | 0.496†|
Range of RD (clock hours) | 4.7 ± 1.5 | 4.6 ± 1.3 | 0.707†|
Macula (on: off) | 23: 18 | 22: 14 | 0.656* |
Superior retinal breaks | Â | Â | Â |
 Number | 1.9 ± 1.0 | 2.1 ± 1.0 | 0.359‡ |
 Total area (PD) | 2.1 ± 1.0 | 2.2 ± 1.0 | 0.646†|
Lens status (phakic: pseudophakic) | 35: 6 | 31: 5 | 0.926* |
Presence of Inferior retinal breaks (yes: no) | 11: 30 | 10: 26 | 0.926* |